5-Chloro-2-iodopyrimidine(CAS: 874676-81-0)

The compound 5-Chloro-2-iodopyrimidine (CAS: 874676-81-0) falls under various regulatory guidelines, including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements for its use as a chemical substance. Specifically, it should be classified and labelled according to the GHS for its hazardous properties, and manufacturers and importers must comply with REACH for registration and evaluation.

While 5-Chloro-2-iodopyrimidine (CAS: 874676-81-0) has specific properties, alternatives include other pyrimidine derivatives such as 2-chloro-5-iodopyrimidine or 5-bromo-2-iodopyrimidine, which can serve similar purposes in synthesis. Other reagents like halogenated analogs or isomers can be used as substitutes based on the specific requirements of the reaction or application.

The market for 5-Chloro-2-iodopyrimidine (CAS: 874676-81-0) is driven by its applications in pharmaceutical research, particularly in the development of antiviral drugs and other medicinal compounds. Research trends indicate a growing interest in its use as a pharmacophore in drug design, reflecting its importance in the biopharmaceutical industry. Market trends suggest increasing demand due to ongoing clinical trials and pharmaceutical advancements.

Waste containing 5-Chloro-2-iodopyrimidine (CAS: 874676-81-0) should be collected in appropriate containers and handled according to local and national regulations. It is recommended to incinerate the waste or use professional waste disposal services to ensure environmental safety. Precautions include proper labeling, avoiding cross-contamination, and following all safety protocols to prevent exposure and environmental pollution.